Emerging evidence suggests that gut microbiota diversity and composition are associated with reduced risks of metabolic syndrome, a condition characterized by abdominal obesity, dyslipidemia, hypertension, and impaired insulin sensitivity [22,23]. This evidence concerns the gene INS and metabolic syndrome.